These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36889644)

  • 1. Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis.
    Luque-Paz D; Cuervo G; Miró JM; Tattevin P
    Clin Microbiol Infect; 2023 Jun; 29(6):676-678. PubMed ID: 36889644
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
    Westbrook KJ; Chilambi GS; Stellfox ME; Nordstrom HR; Li Y; Iovleva A; Shah NH; Jones CE; Kline EG; Squires KM; Miller WR; Tran TT; Arias CA; Doi Y; Shields RK; Van Tyne D
    J Antimicrob Chemother; 2024 Apr; 79(4):801-809. PubMed ID: 38334390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV; Lopez-Cortes LE; Luque-Marquez R; Galvez-Acebal J; de Alarcon-Gonzalez A
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.
    El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM
    J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study.
    Ramos-Martínez A; Pericàs JM; Fernández-Cruz A; Muñoz P; Valerio M; Kestler M; Montejo M; Fariñas MC; Sousa D; Domínguez F; Ojeda-Burgos G; Plata A; Vidal L; Miró JM;
    PLoS One; 2020; 15(8):e0237011. PubMed ID: 32745091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
    Freeman L; Milkovits A; McDaniel L; Everson N
    Int J Antimicrob Agents; 2022 Mar; 59(3):106522. PubMed ID: 35038556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis.
    Sierra-Hoffman M; Iznaola O; Goodwin M; Mohr J
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6064. PubMed ID: 22964255
    [No Abstract]   [Full Text] [Related]  

  • 13. Enterococcal endocarditis revisited.
    Pericás JM; Zboromyrska Y; Cervera C; Castañeda X; Almela M; Garcia-de-la-Maria C; Mestres C; Falces C; Quintana E; Ninot S; Llopis J; Marco F; Moreno A; Miró JM
    Future Microbiol; 2015; 10(7):1215-40. PubMed ID: 26118390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin once-daily in enterococcal endocarditis.
    Bassetti M; Righi E; Crapis M; Cojutti P; Venturini S; Viale P; Pea F
    Int J Cardiol; 2013 Oct; 168(5):5033-4. PubMed ID: 23931973
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of vancomycin-resistant enterococcal endocarditis.
    Brink AJ; van den Ende J; Routier RJ; Devenish L
    S Afr Med J; 2000 Nov; 90(11):1113-5. PubMed ID: 11196031
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci.
    Tripodi MF; Locatelli A; Adinolfi LE; Andreana A; Utili R
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):734-6. PubMed ID: 9865990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
    Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.